Ann: 2021 Annual Report to Shareholders, page-19

Are you saying that Imagion is trying to mislead us? The quote is from page 22 of the company's Full Year Investor Presentation. Also there is more than 2 patients.
From their Full Year Results Release page 1
"2021 Highlights
During 2021, Imagion has continued to make progress in relation to the MagSense® HER2 breast cancer
Phase 1 study for the detection and staging of HER2 metastatic breast cancer. The first patient was
enrolled into the study in May 2021 with additional patients enrolling as new study sites were activated."

So after the first patient there were additional patients (plural)

Cheers